All In Biotech

Drug Trial Radar · NCT07851259

A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

A Phase II, Randomized, Double-Masked, Placebo-Controlled Multicenter Study to Assess the Efficacy and Safety of RO7965032 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 321 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

321

Planned (sponsor's estimate)

Start

Jan 8, 2027

Primary completion

Aug 21, 2030

Study completion Aug 21, 2030

Sponsor

Lead sponsor
Genentech, Inc.Roche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Oct 1, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the safety and efficacy of RO7965032 to address a significant unmet medical need in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD)

Conditions

  • Geographic Atrophy Secondary to Age-Related Macular Degeneration

Interventions

  • RO7965032Drug

    RO7965032 will be administered as per the schedule defined in the protocol.

  • PlaceboDrug

    Placebo will be administered as per the schedule defined in the protocol.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change of GA Lesion Area in the Study EyeTime frame: Baseline up to approximately 48 weeks
  2. Incidence and Severity of Ocular Adverse Events (AEs)Time frame: Up to approximately 72 Weeks
  3. Incidence and Severity of Non-Ocular AEsTime frame: Up to approximately 72 Weeks

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Bay Area Retina Specialists Medical Group - Vestrum - PPDS

    Walnut Creek, California · Recruiting

  • Piedmont Retina Specialists

    Winston-Salem, North Carolina · Recruiting

  • Erie Retina Research

    Erie, Pennsylvania · Recruiting

  • Texas Retina Associates - Arlington

    Arlington, Texas · Recruiting

  • Piedmont Eye Center

    Lynchburg, Virginia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.